Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

MDEs Increasing for Female Juvenile Offenders

Compr Psychiatry; ePub 2017 Sep 12; Holzer, et al

The prevalence of past year major depressive episodes (MDEs) is increasing for female juvenile offenders, highlighting a need for improved efforts to target these populations for prevention and treatment, a recent study found. Data were collected between 2005 and 2014 as part of the National Survey on Drug Use and Health (NSDUH). Participants included 171,118 youth aged 12–17 (159,449 non-offenders and 11,669 offenders). The primary variable of interest was self-reported past year MDE. Researchers found:

  • The prevalence of MDEs among female youth increased for both offender and non-offender groups: from 24.4% to 33.0% for the offenders and from 12.4% to 16.7% for the non-offenders.
  • No significant trend changes were observed among male youth.
  • In both male and female juvenile offenders, MDEs were associated with increased risk of illicit drug use (males OR=1.61; females OR=1.83).
  • Additional correlates include alcohol use among male offenders (OR = 1.36), and binge drinking in female offenders (OR=1.24).

Citation:

Holzer KJ, Oh S, Salas-Wright CP, Vaughn MG, Landess J. Gender differences in the trends and correlates of major depressive episodes among juvenile offenders in the United States. [Published online ahead of print September 12, 2017]. Compr Psychiatry. doi:10.1016/j.comppsych.2017.09.005.

This Week's Must Reads

Study: Gender Is Central to Sexual Attraction, J Sex Res; ePub 2017 Nov 30; Schudson, et al

High-Risk Patients, Low-Volume Opioid Prescribers, Addiction; ePub 2017 Nov 29; Chang, Murimi, et al

Potential Risk Factors for Nonsuicidal Self-Injury, Psychiatry Res; ePub 2017 Nov 30; Fox, et al

FDA Grants Approval for Opioid Withdrawal Device, FDA news release; 2017 Nov 15

FDA Approves First US Digital Medicine System, FDA news release; 2017 Nov 14

Must Reads in Addiction Medicine

High-Risk Patients, Low-Volume Opioid Prescribers, Addiction; ePub 2017 Nov 29; Chang, Murimi, et al

FDA Grants Approval for Opioid Withdrawal Device, FDA news release; 2017 Nov 15

New Synthetic Cannabinoids May Pose Health Risk, Am J Addictions; ePub 2017 Nov 6; Papadopoulos, et al

Intervention Did Not Reduce Alcohol/Marijuana Use, Addiction; ePub 2017 Oct 16; Stein, Caviness, et al

Genetic Link to Alcohol Dependence and Depression, JAMA Psychiatry; ePub 2017 Oct 25; Zhou, et al